D-(+)-Methyl-alpha-(2-thienylethamino)(2-chlorophenyl)acetate hydrochloride

We are D-(+)-Methyl-alpha-(2-thienylethamino)(2-chlorophenyl)acetate hydrochloride CAS:141109-19-5 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name: D-(+)-Methyl-alpha-(2-thienylethamino)(2-chlorophenyl)acetate hydrochloride
CAS.NO:  141109-19-5
Synonyms:
Methyl (αS)-2-chloro-α-[[2-(2-thienyl)ethyl]amino]benzeneacetate hydrochloride (1:1)
Methyl-(S)-(+)-(2-chlorophenyl)[(2-(2-thienyl)amino]acetate hydrochloride
Methyl (2S)-(2-chlorophenyl){[2-(2-thienyl)ethyl]amino}acetate hydrochloride (1:1)
Benzeneacetic acid, 2-chloro-α-[[2-(2-thienyl)ethyl]amino]-, methyl ester, (αS)-, hydrochloride (1:1)

Molecular Formula: C15H17Cl2NO2S
Molecular Weight: 346.272

Physical and Chemical Properties:
Density: /
Boiling point: 483.8ºC at 760 mmHg
Melting point: /
Flash point:246.4ºC
Refractive index: /

Specification:
Appearance:white or almost white power
Purity:≥98%
Loss on drying: NMT 0.5%
otol Impurity :0.5% max;
Single Impurity: 0.15% max

Packing:
 25kg  cardboard drum or according to customer specified requirements
Storage:Stored in a cool and dry well-closed container. Keep away from moisture and strong light/heat.
Application:Intermediates of Clopidogrel sulfate  CAS:120202-66-6
Intermediates of Clopidogrel  CAS:113665-84-2
Intermediates of Clopidogrel camphorsulfonate  CAS:120202-68-8

Related News: Judging from the geographical distribution of enterprises, the largest distribution of API companies is Jiangsu and Zhejiang, with more than 300 enterprises; followed by Shandong, Sichuan and Hubei.2 – [(2-metoxifenoxi) metil] oxirano CAS:2210-74-4 First of all, as an API manufacturer we think of how to make a chemical compound which becomes an API in the laboratory.1200-03-9 We have leading expertise in strategy and operational implementation of pre-approval access programs making pharmaceutical products under clinical development available for patients and Inceptua’s clinical trial services business offers high quality clinical comparator sourcing and manufacturing services with an agile global supply chain to ensure that products are delivered exactly when needed.20885-12-5 Madeleine Roche, Associate Pharmaceutical Analyst at GlobalData, comments: “Within the top 20 global companies that spent the most on R&D in 2018, the top spender – despite having the second smallest annual revenue of the group at $15.28 billion – is Celgene, whose R&D spend was equal to 37% of its annual revenue.At present, China’s bulk drug industry is mainly focused on bulk drug substances, and there is huge room for development in terms of specialty drug substances and patented drug substances.